Allspring Global Investments
CYTK icon

Allspring Global Investments’s Cytokinetics CYTK Stock Holding History

Allspring Global Investments’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Buy
7,531
+542
+8% +$38.9K ﹤0.01% 1383
2026
Q1 		$466K Buy
6,989
+646
+10% +$41.1K ﹤0.01% 1407
2025
Q4 		$392K Buy
6,343
+679
+12% +$42.2K ﹤0.01% 1438
2025
Q3 		$316K Buy
+5,664
New +$233K ﹤0.01% 1467
2025
Q2 		– Sell
-5,763
Closed -$216K – 1664
2025
Q1 		$216K Sell
5,763
-78,258
-93% -$3.6M ﹤0.01% 1646
2024
Q4 		$4.11M Sell
84,021
-9,278
-10% -$482K 0.01% 983
2024
Q3 		$4.93M Buy
93,299
+5,487
+6% +$306K 0.01% 948
2024
Q2 		$4.76M Buy
87,812
+84,396
+2,471% +$5.09M 0.01% 969
2024
Q1 		$239K Buy
3,416
+558
+20% +$43.2K ﹤0.01% 1671
2023
Q4 		$239K Sell
2,858
-1,644
-37% -$59.5K ﹤0.01% 1657
2023
Q3 		$133K Sell
4,502
-20,534
-82% -$684K ﹤0.01% 1898
2023
Q2 		$817K Sell
25,036
-174,881
-87% -$6.47M ﹤0.01% 1464
2023
Q1 		$7.04M Buy
199,917
+6,157
+3% +$251K 0.01% 895
2022
Q4 		$8.88M Buy
193,760
+1,405
+0.7% +$60.5K 0.02% 810
2022
Q3 		$9.32M Buy
192,355
+6,462
+3% +$311K 0.02% 800
2022
Q2 		$7.3M Sell
185,893
-31,055
-14% -$1.25M 0.01% 871
2022
Q1 		$7.99M Sell
216,948
-1,381
-0.6% -$49.1K 0.01% 965
2021
Q4 		$9.95M Buy
+218,329
New +$8.42M 0.01% 922

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's CYTK Position: Q2 2026 in Review

Allspring Global Investments increased its Cytokinetics (CYTK) stake by 7.8% in Q2 2026, buying an estimated $38.9K and bringing the position to 7,531 shares worth $642K. The position accounts for ﹤0.01% of the portfolio, ranked #1383.

Allspring Global Investments first reported a position in CYTK in Q4 2021 and has held it in 18 quarters since. The position peaked at $9.95M in Q4 2021. 482 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Allspring Global Investments held 7,531 shares of Cytokinetics worth $642K as of Q2 2026.
  • Allspring Global Investments bought 542 Cytokinetics shares in Q2 2026, an estimated $38.9K.
  • Cytokinetics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1383 holding.
  • Allspring Global Investments first reported a position in Cytokinetics in Q4 2021 and has held it in 18 quarters since.
  • Allspring Global Investments's Cytokinetics position peaked at $9.95M in Q4 2021.
  • 482 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.